BACKGROUND: (99m)Tc-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liver function. The aim of this study was to compare future remnant liver function assessed by (99m)Tc-mebrofenin hepatobiliary scintigraphy with future remnant liver volume in the prediction of liver failure after major liver resection. METHODS: Computed tomography (CT) volumetry and (99m)Tc-mebrofenin hepatobiliary scintigraphy were performed prior to major resection in 55 high-risk patients, including 30 patients with parenchymal liver disease. Liver volume was expressed as percentage of total liver volume or as standardized future remnant liver volume. Receiver operating characteristic (ROC) curve analysis was performed to identify a cutoff value for future remnant liver function in predicting postoperative liver failure. RESULTS: Postoperative liver failure occurred in nine patients. A liver function cutoff value of 2.69%/min/m(2) was calculated by ROC curve analysis. (99m)Tc-mebrofenin hepatobiliary scintigraphy demonstrated better sensitivity, specificity, and positive and negative predictive value compared to future remnant liver volume. Using 99mTc-mebrofenin hepatobiliary scintigraphy, one cutoff value suffices in both compromised and noncompromised patients. CONCLUSION: Preoperative (99m)Tc-mebrofenin hepatobiliary scintigraphy is a valuable technique to estimate the risk of postoperative liver failure. Especially in patients with uncertain quality of the liver parenchyma, (99m)Tc-mebrofenin HBS proved of more value than CT volumetry.
BACKGROUND: (99m)Tc-mebrofeninhepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liver function. The aim of this study was to compare future remnant liver function assessed by (99m)Tc-mebrofeninhepatobiliary scintigraphy with future remnant liver volume in the prediction of liver failure after major liver resection. METHODS: Computed tomography (CT) volumetry and (99m)Tc-mebrofeninhepatobiliary scintigraphy were performed prior to major resection in 55 high-risk patients, including 30 patients with parenchymal liver disease. Liver volume was expressed as percentage of total liver volume or as standardized future remnant liver volume. Receiver operating characteristic (ROC) curve analysis was performed to identify a cutoff value for future remnant liver function in predicting postoperative liver failure. RESULTS:Postoperative liver failure occurred in nine patients. A liver function cutoff value of 2.69%/min/m(2) was calculated by ROC curve analysis. (99m)Tc-mebrofeninhepatobiliary scintigraphy demonstrated better sensitivity, specificity, and positive and negative predictive value compared to future remnant liver volume. Using 99mTc-mebrofeninhepatobiliary scintigraphy, one cutoff value suffices in both compromised and noncompromised patients. CONCLUSION: Preoperative (99m)Tc-mebrofeninhepatobiliary scintigraphy is a valuable technique to estimate the risk of postoperative liver failure. Especially in patients with uncertain quality of the liver parenchyma, (99m)Tc-mebrofenin HBS proved of more value than CT volumetry.
Authors: J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi Journal: Surgery Date: 2000-05 Impact factor: 3.982
Authors: W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart Journal: Ann Surg Date: 2001-10 Impact factor: 12.969
Authors: Deha Erdogan; Bob H M Heijnen; Roelof J Bennink; Mariël Kok; Sander Dinant; Irene H Straatsburg; Dirk J Gouma; Thomas M van Gulik Journal: Liver Int Date: 2004-04 Impact factor: 5.828
Authors: Sander Dinant; Michael F Gerhards; Olivier R C Busch; Hugo Obertop; Dirk J Gouma; Thomas M Van Gulik Journal: HPB (Oxford) Date: 2005 Impact factor: 3.647
Authors: Roelof J Bennink; Sander Dinant; Deha Erdogan; Bob H Heijnen; Irene H Straatsburg; Arlene K van Vliet; Thomas M van Gulik Journal: J Nucl Med Date: 2004-06 Impact factor: 10.057
Authors: Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong Journal: J Gastrointest Surg Date: 2003 Mar-Apr Impact factor: 3.452
Authors: Robert J S Coelen; Jimme K Wiggers; Chung Y Nio; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik Journal: HPB (Oxford) Date: 2015-02-28 Impact factor: 3.647
Authors: Sandra van der Velden; Manon N G J A Braat; Tim A Labeur; Mike V Scholten; Otto M van Delden; Roelof J Bennink; Hugo W A M de Jong; Marnix G E H Lam Journal: J Nucl Med Date: 2019-04-06 Impact factor: 10.057
Authors: Kasia P Cieslak; Roelof J Bennink; Wilmar de Graaf; Krijn P van Lienden; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik Journal: HPB (Oxford) Date: 2016-07-25 Impact factor: 3.647
Authors: Julie A Fitzpatrick; Jin Un Kim; Jeremy F L Cobbold; Mark J W McPhail; Mary M E Crossey; Aluel A Bak-Bol; Ashraf Zaky; Simon D Taylor-Robinson Journal: J Clin Exp Hepatol Date: 2015-12-06